It was found that, compared to normal and BPH tissues, the expression of PSGR increased significantly in PIN and prostate tumors (approximately 10-fold), especially in early prostate cancer, suggesting PSGR has the potential for early PCa detection (AUC of 0.902) [66]. Here, OR51E2 is linked to prostate neoplasm.